Statement from Shatterproof on DEA's Temporary Scheduling of 7-Hydroxymitragynine (7-OH) and Related Substances
WASHINGTON, July 2, 2026 /PRNewswire/ -- Shatterproof applauds the U.S. Drug Enforcement Administration's decision to temporarily schedule 7-hydroxymitragynine (7-OH) and related substances. This is an important and long-overdue step toward addressing the rapid proliferation of highly...
WASHINGTON, July 2, 2026 /PRNewswire/ -- Shatterproof applauds the U.S. Drug Enforcement Administration's decision to temporarily schedule 7-hydroxymitragynine (7-OH) and related substances. This is an important and long-overdue step toward addressing the rapid proliferation of highly...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.